[Hinews] Incheon, South Korea — On July 21, The Catholic University of Korea Incheon St. Mary's Hospital held a ceremony to honor Professor Jung Jun Kim, director of its Robotic Surgery Center and a urology specialist, for completing 2,000 robotic urological surgeries, marking the fastest milestone of its kind by any surgeon at a single institution in South Korea—and achieved by the youngest to date.

Professor Kim began performing robotic surgeries at the hospital in 2019 and reached the 2,000-surgery mark in just six years. An expert in robotic surgery for renal and prostate cancers, Kim introduced the clinical use of ischemia-free partial nephrectomy (i.e., a surgery performed without cutting off blood supply to the kidney) in South Korea—a procedure that removes cancerous tissue while preserving kidney function. He has performed over 800 such surgeries, the highest number in South Korea and one of the leading volumes in Asia.

Professor Jung Jun Kim, director of the Robotic Surgery Center at Incheon St. Mary's Hospital, marks the completion of 2,000 robotic urological surgeries. (Photo courtesy of Incheon St. Mary's Hospital)
Professor Jung Jun Kim, director of the Robotic Surgery Center at Incheon St. Mary's Hospital, marks the completion of 2,000 robotic urological surgeries. (Photo courtesy of Incheon St. Mary's Hospital)
Kim has also contributed to advancing robotic surgical techniques for adrenal tumors, bladder cancer, and other urological malignancies, solidifying his role as a leader in urological robotic surgery in South Korea.

During the ceremony, Intuitive Surgical Korea—the maker of the da Vinci robotic surgical system, officially recognized Kim’s 2,000-case milestone and commended his dedication to patient-centered surgical care.

“This milestone reflects the trust our patients place in us to deliver better treatment,” Kim said at the ceremony. “I am committed to continuing compassionate care to support patients in their fight against cancer.”

키워드

#인천성모병원#로봇수술#김정준교수#비뇨의학과
저작권자 © Hinews 무단전재 및 재배포 금지
ad